Outcome of the Board Meeting is enclosed
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Everest Organics met over two days (May 27-28, 2025) and approved three auditor-related decisions. It appointed M/s. RPR & Associates, Practicing Company Secretaries based in Hyderabad, as the new Secretarial Auditor for a five-year term from FY 2025-26 to FY 2029-30, subject to shareholder approval at the upcoming 32nd AGM. The Board also re-appointed M/s. Harikrishna & Associates as Internal Auditors for FY 2025-26 and M/s. P.K.R. & Associates LLP as Cost Auditors for FY 2025-26, the latter also needing shareholder approval for remuneration. No financial results, business updates, or operational matters were discussed in this filing.
This is a routine corporate governance announcement with no direct impact on shareholders' wealth or stock price. Investors should note that the shareholder approvals sought at the AGM are standard procedural items.